#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2598	16S	1529	1529	99.93	16S.l15.c17.ctg.1	3024	201.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	2276	2276	T	317	TCC,TC	293,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	2598	16S	1529	1529	99.93	16S.l15.c17.ctg.1	3024	201.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	2010	2010	C	223	C,G,A	215,1,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5092	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4431	279.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	2113	2113	A	303	A,C,G	296,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5092	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4431	279.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2747	2747	C	388	C,A,G	377,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5092	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4431	279.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2821	2821	A	390	A,C	379,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5092	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4431	279.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	3373	3373	C	376	C,A	364,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	5092	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4431	279.7	0	HET	.	.	.	C709T,A	.	709	709	C	1485	1485	C	279	C,T,A	187,79,1	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1100	folP	855	855	100.0	folP.l15.c4.ctg.1	2116	123.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1412	1414	AGC	142;142;140	A;G;C	134;137;134	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1718	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	4004	104.5	1	SNP	p	S91F	1	.	.	271	273	TTC	854	856	TTC	90;90;91	T;T;C	81;79;85	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1718	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	4004	104.5	1	SNP	p	G95N	0	.	.	283	285	GGC	866	868	GGC	100;101;101	G;G;C,A	95;95;89,2	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1718	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	4004	104.5	1	SNP	p	D95G	1	.	.	283	285	GGC	866	868	GGC	100;101;101	G;G;C,A	95;95;89,2	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1718	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	4004	104.5	0	HET	.	.	.	G2374A,C	.	2374	2374	G	2957	2957	G	104	G,A,C	62,9,8	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	155	1718	gyrA	2751	2751	99.96	gyrA.l15.c30.ctg.1	4004	104.5	0	HET	.	.	.	G2377A,C	.	2377	2377	G	2960	2960	G	103	G,A,C	67,13,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	598	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	2197	66.3	1	SNP	p	G45D	0	.	.	133	135	GGC	949	951	GGC	156;157;157	G;G;C,G	147;141;145,1	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	434	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1737	60.3	0	.	n	.	0	A197.	DEL	197	197	A	1003	1003	A	139	A	137	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1498	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3599	101.1	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1849	1851	GTC	153;152;152	G;T;C	141;136;142	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1498	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3599	101.1	1	SNP	p	D86N	0	.	.	256	258	GAC	955	957	GAC	85;85;88	G,C;A,G;C	65,1;56,1;73	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1498	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3599	101.1	1	SNP	p	R87I	0	.	.	259	261	CGT	958	960	CGT	91;93;97	C;G;T	80;63;75	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1498	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3599	101.1	1	SNP	p	S87R	1	.	.	259	261	CGT	958	960	CGT	91;93;97	C;G;T	80;63;75	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1498	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3599	101.1	1	SNP	p	R87W	0	.	.	259	261	CGT	958	960	CGT	91;93;97	C;G;T	80;63;75	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1498	parC	2304	2304	99.87	parC.l15.c4.ctg.1	3599	101.1	1	SNP	p	S88P	0	.	.	262	264	TCC	961	963	TCC	97;95;95	T;C,T;C	78;78,1;87	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1754	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3346	127.3	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1783	1785	TGC	179;179;180	T,G;G;C,G	142,2;156;151,1	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	1754	parE	1986	1986	99.95	parE.l15.c4.ctg.1	3346	127.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1993	1995	GGC	129;129;129	G,C;G;C	110,1;109;102	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1542	1544	GCA	128;129;129	G,T;C,A;A	116,1;118,1;121	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1545	1547	ATC	129;130;130	A;T,C;C	115;124,1;125	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1557	1559	GTG	124;122;122	G,C;T,G;G	119,1;114,3;118	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1557	1559	GTG	124;122;122	G,C;T,G;G	119,1;114,3;118	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2061	2063	ACC	74;76;71	A;C;C	56;61;62	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2115	2117	GCG	55;55;55	G;C;G	43;46;44	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2115	2117	GCG	55;55;55	G;C;G	43;46;44	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2238	2240	GGC	72;74;75	G;G,T;C,T,G	70;71,1;70,3,1	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2247	2249	GGC	70;71;70	G;G;C	65;49;40	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	1749	100.0	penA.l6.c17.ctg.1	2583	88.1	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2265	2267	TCG	79;77;77	T,G;C,T,G;G	43,3;54,1,1;68	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	783	992	penA	1749	299	99.67	penA.l6.c17.ctg.2	637	1.5	0	.	p	.	0	L268fs	FSHIFT	802	802	T	510	510	A	4	A	1	.	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1174	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3996	70.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2056	2058	CCG	118;119;118	C,G,T;C,G,A;G,C	92,3,2;103,1,1;67,9	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	688	porA	1146	1146	99.56	porA.l15.c4.ctg.1	2533	66.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	934	934	C	55	C	49	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	56	porB1a	984	93	95.7	porB1a.l6.c17.ctg.1	1231	7.0	0	.	p	.	0	M18T	NONSYN	52	54	ATG	741	743	ACG	23;23;23	A;C;G	23;23;21	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	594	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2538	56.9	0	.	p	.	0	N38E	NONSYN	112	114	AAT	821	823	GAA	92;94;96	G;A,G;A	88;89,1;93	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	594	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2538	56.9	0	.	p	.	0	N134D	NONSYN	400	402	AAT	1109	1111	GAT	85;91;91	G;A;T	79;87;83	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	594	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2538	56.9	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1232	1234	TCA	76;76;76	T,G,C;C;A	72,1,1;72;75	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	594	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2538	56.9	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1361	1363	GTC	67;69;70	G,T;T,G;C,T	58,1;65,1;64,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	594	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2538	56.9	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1691	1693	GCA	86;88;86	G;C;A,T	84;87;83,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	594	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2538	56.9	1	SNP	p	G120K	1	.	.	358	360	AAG	1067	1069	AAG	103;102;102	A,C;A,C;G,T,C	101,1;98,2;98,1,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	594	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2538	56.9	1	SNP	p	A121D	1	.	.	361	363	GAC	1070	1072	GAC	102;101;101	G,A;A;C,A	99,1;99;97,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	594	porB1b	1047	1047	99.33	porB1b.l15.c4.ctg.1	2538	56.9	1	SNP	p	D121N	0	.	.	361	363	GAC	1070	1072	GAC	102;101;101	G,A;A;C,A	99,1;99;97,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	1362	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5517	60.0	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2282	2284	AAT	62;62;62	A;A;T	62;62;62	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	148	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1726	20.6	1	SNP	p	V57M	1	.	.	169	171	ATG	871	873	ATG	38;38;39	A;T;G	35;35;36	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
